Kinnate Biopharma
Why Robinhood?
You can watch KNTE and buy or sell other stocks, ETFs, and their options commission-free!About KNTE
Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W.
KNTE Key Statistics
Stock Snapshot
Kinnate Biopharma(KNTE) stock is priced at $2.65, giving the company a market capitalization of 125.15M. It carries a P/E multiple of -1.09.
On 2026-04-01, Kinnate Biopharma(KNTE) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Kinnate Biopharma(KNTE) stock has reached 0, versus its average volume of 367.46K.
Over the past 52 weeks, Kinnate Biopharma(KNTE) stock has traded between a high of $6.00 and a low of $1.04.
Over the past 52 weeks, Kinnate Biopharma(KNTE) stock has traded between a high of $6.00 and a low of $1.04.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.